Skip to content
Results research

Concall Intelligence

Follow the Sept 2026 quarter results season by comparing what companies reported with what management said next. Search official call evidence, measurable guidance, changing outlook, operating risks, and prior commitments without treating commentary as a trading recommendation.

Open reported results
Matching calls
14
After selected filters
Transcript verified
12
Official transcript summaries on this page
Preliminary briefs
2
Presentation evidence, clearly labelled
Processing
0
Transcript filed or call source found
Tracked companies
0
Watchlist or portfolio matches
Search companies or transcript phrases

Management evidence

Generated 5 Nov, 5:56 am IST · click a summary to inspect source-linked evidence for this results quarter.

Clear filters
CompanyCall and sourcesReported resultManagement outlookEvidence-led conclusionReview
PINELABS
Pine Labs Limited
Financial Services · Small
Sept 2026
4 Nov 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Pine Labs reported strong financial results for Q2 FY2027 with revenue of 806.2Cr and PAT of 38.6Cr, representing robust YoY and QoQ expansions. Growth was broad-based across offline enterprise, mid-market terminal deployments, flow-based income, and issuing operations, while international markets also showed healthy scale. Management remains confident about H2 performance and investments in sales expansion despite rising indirect costs and capex.

Evidence summary ready
BIRLANU
BirlaNu Limited
Diversified · Small
Sept 2026
3 Nov 2026
Preliminary brief
Bad
12/100
Cautious outlook
No comparable prior call
No measurable guidance

BirlaNu Limited (formerly HIL Limited) reported consolidated revenue of 884.5 Cr for Q2 FY27, up 9.2% YoY, driven by solid domestic growth across Roofs, Walls, and Pipes. However, consolidated profitability remained constrained with a net loss of 57.4 Cr, impacted by weakness in the European flooring subsidiary Parador and an exceptional provision of 90 Cr towards diminution in the value of investment in BirlaNu International GmbH.

Evidence summary ready
SAMBHV
Sambhv Steel Tubes Limited
Metals · Small
Sept 2026
3 Nov 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Sambhv Steel Tubes Limited reported robust Q2 FY27 performance with revenue of INR836 crores and PAT of INR61 crores, driven by value-added volume growth, despite some sequential normalization in stainless steel EBITDA margins due to QCO relaxation and Chinese dumping.

Evidence summary ready
JTLIND
JTL INDUSTRIES LIMITED
Consumer · Small
Sept 2026
3 Nov 2026
Preliminary brief
Average
52/100
Bullish outlook
No comparable prior call
No measurable guidance

Management's strategic focus on scaling value-added products and expanding capacity is yielding robust volume growth and improved absolute profitability, though sequential realization stability requires close monitoring as capacity ramps up.

Evidence summary ready
ARKADE
Arkade Developers Limited
Real Estate · Small
Sep 2026
2 Nov 2026
Transcript verified
Bad
0/100
Optimistic outlook
No comparable prior call
No measurable guidance

Arkade Developers Limited reported lower year-on-year revenue and PAT for Q2 FY27 due to a high base effect from the previous year when four projects crossed revenue recognition thresholds, but maintained strong net cash and healthy collections growth.

Evidence summary ready
STAR
Strides Pharma Science Limited
Pharma · Micro
Sep 2026
2 Nov 2026
Transcript verified
Average
42/100
Optimistic outlook
No comparable prior call
Guidance maintained

Strides Pharma Science Limited delivered its highest-ever quarterly revenue of INR 14,297 million and robust absolute EBITDA of INR 2,509 million in Q2 FY27, supported by strong momentum in its Ex-US business which outpaced the US segment. Margin pressures persisted due to geopolitical-driven freight and raw material cost inflation, and inventory investments led to a temporary elevation in working capital and net debt. The overall FY28 revenue ambition remains intact, though

Evidence summary ready
PAYTM
One 97 Communications Limited
Financial Services · Mid
Sep 2026
30 Oct 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
No measurable guidance

Paytm delivered strong Q2 FY27 performance with robust revenue growth, improved profitability, and significant traction in monthly transacting users, while maintaining strict discipline around profitable GMV and awaiting UPI MDR implementation.

Evidence summary ready
SSWL
Steel Strips Wheels Limited
Auto · Small
Sept 2026
30 Oct 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance maintained

Steel Strips Wheels Limited (SSWL) delivered its strongest quarter in history during Q2 FY27, marked by record revenue, EBITDA, and PAT. Performance was driven by premiumization, robust CV and tractor demand, export recovery, and improved aluminum wheel contributions, supported by ongoing operational efficiencies and customer price realizations.

Evidence summary ready
BLUESTONE
BlueStone Jewellery and Lifestyle Limited
Consumer · Micro
Sept 2026
30 Oct 2026
Transcript verified
Average
45/100
Optimistic outlook
No comparable prior call
No measurable guidance

BlueStone reported a strong Q2 FY27 with revenue growing 44% YoY to INR 738 crores and EBITDA more than doubling, marking its fourth consecutive profitable quarter on a standalone basis. Management highlighted crossing 1 million cumulative customers and emphasized an omnichannel strategy focusing on lightweight jewellery and entry-level price point redesigns to drive future growth.

Evidence summary ready
BANSALWIRE
Bansal Wire Industries Limited
Industrials · Small
Sep 2026
28 Oct 2026
Transcript verified
Excellent
90/100
Optimistic outlook
No comparable prior call
Guidance maintained

Bansal Wire Industries delivered a record financial performance in Q2 FY27, achieving its highest-ever quarterly revenue, EBITDA, PAT, and EBITDA per ton, driven by economies of scale at the expanded Dadri facility, improved product mix, and working capital optimization.

Evidence summary ready
HFCL
HFCL Limited
Telecom · Large
Sept 2026
26 Oct 2026
Transcript verified
Excellent
100/100
Optimistic outlook
No comparable prior call
Guidance raised

HFCL reported its best-ever quarterly performance in Q2 FY27, driven by surging export demand, high-margin data center connectivity solutions, and scale benefits, though some EPC segment losses persist.

Evidence summary ready
SOLARA
Solara Active Pharma Sciences Limited
Healthcare · Small
Sep 2026
23 Oct 2026
Transcript verified
Good
55/100
Optimistic outlook
No comparable prior call
No measurable guidance

Solara Active Pharma Sciences reported its strongest quarter in five years for Q2 FY27, with revenue growing 33% YoY to INR418 crores and EBITDA doubling to INR77 crores, driven by a resilient base business and temporary market-driven recovery in Ibuprofen. However, management highlighted ongoing macroeconomic headwinds, including raw material availability and West Asia crisis pressures, and requested patience regarding the strategic review of the Ibuprofen business.

Evidence summary ready
CANBK
Canara Bank
Financial Services · Large
Sept 2026
17 Oct 2026
Transcript verified
Average
50/100
Optimistic outlook
No comparable prior call
Guidance maintained

Canara Bank reported a strong set of results for Q2 FY27 with total global business crossing ₹30 lakh crores and net profit reaching a record ₹5,175 crore, supported by robust advances growth and improving asset quality.

Evidence summary ready
ICICIAMC
ICICI Prudential Asset Management Company Limited
Financial Services · Mid
Sept 2026
16 Oct 2026
Transcript verified
Average
42/100
Optimistic outlook
No comparable prior call
No measurable guidance

ICICI Prudential AMC reported Q2 FY2027 operating revenue of Rs 1,674 crore (up 16.3% YoY, 7% QoQ) and operating PBT of Rs 1,181 crore (up 15.7% YoY, 7.4% QoQ), with profit after tax at Rs 889 crore, while management maintains focus on long-term systemic flows and expanding alternate and SIF products despite choppy market conditions and elevated redemptions.

Evidence summary ready
Method: Deterministic quarterly-result score from reported growth, margin direction and operating leverage. Derived only from extracted, source-linked management evidence. Pending is shown when evidence is insufficient. Measurable claims are separated from general commentary and retain outcome status when later evidence exists. Transcript-verified summaries rank above preliminary presentation briefs and source-only call evidence. Preliminary briefs are replaced automatically when an official transcript is processed. Management outlook and colours describe extracted commentary evidence; they are not buy or sell labels.